<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="review-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Med Oral Patol Oral Cir Bucal</journal-id><journal-id journal-id-type="iso-abbrev">Med Oral Patol Oral Cir Bucal</journal-id><journal-id journal-id-type="publisher-id">Medicina Oral S.L.</journal-id><journal-title-group><journal-title>Medicina Oral, Patolog&#x000ed;a Oral y Cirug&#x000ed;a Bucal</journal-title></journal-title-group><issn pub-type="ppub">1698-4447</issn><issn pub-type="epub">1698-6946</issn><publisher><publisher-name>Medicina Oral S.L.</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39864086</article-id><article-id pub-id-type="pmc">PMC11972643</article-id>
<article-id pub-id-type="publisher-id">26439</article-id><article-id pub-id-type="doi">10.4317/medoral.26439</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject><subj-group><subject>Oral Surgery</subject></subj-group></subj-group></article-categories><title-group><article-title>The influence of Dexmedetomidine as an additive to local anesthetics in dental procedures: A systematic review</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Diniz</surname><given-names>Dem&#x000f3;stenes Alves</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>de Fran&#x000e7;a</surname><given-names>Arthur Jos&#x000e9; Barbosa</given-names></name><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Laureano-Filho</surname><given-names>Jos&#x000e9; Rodrigues</given-names></name><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Pellizzer</surname><given-names>Eduardo Piza</given-names></name><xref rid="A4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name><surname>de Moraes</surname><given-names>Sandra L&#x000fa;cia Dantas</given-names></name><xref rid="A5" ref-type="aff">5</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Vasconcelos</surname><given-names>Belmiro Cavalcanti do Egito</given-names></name><xref rid="A6" ref-type="aff">6</xref></contrib></contrib-group><aff id="A1"><label>1</label>M.Sc. student. Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, University of Pernambuco (UPE), Recife, PE, Brazil</aff><aff id="A2"><label>2</label>Ph.D. student. Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, University of Pernambuco (UPE), Recife, PE, Brazil</aff><aff id="A3"><label>3</label>Associate Professor. Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, University of Pernambuco (UPE), Recife, PE, Brazil</aff><aff id="A4"><label>4</label>Full Professor. Department of Dental Materials and Prosthodontics, S&#x000e3;o Paulo State University (UNESP), Ara&#x000e7;atuba, SP, Brazil</aff><aff id="A5"><label>5</label>Associate Professor. Division of Oral Rehabilitation, Faculty of Dentistry, University of Pernambuco (UPE), Recife, PE, Brazil</aff><aff id="A6"><label>6</label>Associate Professor. Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, University of Pernambuco (UPE), Recife, PE, Brazil</aff><author-notes><corresp> Department of Oral and Maxillofacial Surgery
Dental School, University of Pernambuco
Arn&#x000f3;bio Marques St., 310
Zip code 50100-130, Recife, PE, Brazil
, E-mail: <email>belmiro.vasconcelos@upe.br</email></corresp></author-notes><pub-date pub-type="ppub"><month>3</month><year>2025</year></pub-date><pub-date pub-type="epub"><day>26</day><month>1</month><year>2025</year></pub-date><volume>30</volume><issue>2</issue><fpage>e160</fpage><lpage>e169</lpage><history><date date-type="accepted"><day>16</day><month>12</month><year>2024</year></date><date date-type="received"><day>5</day><month>11</month><year>2024</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; 2025 Medicina Oral S.L.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/2.5/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title>Background </title><p> This review aimed to assess if the use of dexmedetomidine as an additive to local anesthetics promotes greater safety and efficacy than local anesthetics alone in dental procedures.</p></sec><sec><title>Material and Methods </title><p> the systematic review was structured according to the PICO strategy and adhered to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) checklist. Studies were included based on the eligibility criteria, and data from the included studies were collected by one author. An additional author reviewed the compilation. Altogether, nine studies were included: eight randomized clinical trials and one controlled clinical trial. Of these, six were related to tooth extraction. Most studies reported the use of lidocaine as the local anesthetic. Levobupivacaine was used in one study.</p></sec><sec><title>Results </title><p> In total, 352 patients were evaluated. Despite the heterogeneity between studies, it can be suggested that when used as an additive to local anesthetics, dexmedetomidine has the potential to decrease postoperative pain and latency period and prolong anesthetic duration.</p><p>Conclusion: There are scant reviews that summarizes the effectiveness of dexmedetomidine as an adjuvant to local anesthetics. These studies can positively impact the lives of the concerned population.</p><p><bold> Key words:</bold>Anesthetics, adjuvants anesthesics, dexmedetomidine, oral surgery, systematic review.</p></sec></abstract></article-meta></front><body><sec><title>Introduction</title><p>Pain continues to remain a major concern in many patients despite significant advances in the field of pain management in dentistry (<xref rid="B1" ref-type="bibr">1</xref>). Local anesthetic solutions are routinely used in dental procedures to reduce pain using reversible nerve blocks (<xref rid="B2" ref-type="bibr">2</xref>,<xref rid="B3" ref-type="bibr">3</xref>). The choice of drug to be used as an anesthetic agent is based on three main considerations: potency, latency (time of onset of anesthesia), and duration of the anesthetic effect (<xref rid="B4" ref-type="bibr">4</xref>).</p><p>Adjuvants are co-administered with local anesthetic agents to improve the onset and/or duration of anesthesia (<xref rid="B5" ref-type="bibr">5</xref>). Epinephrine is one of the most commonly used adjuvants in combination with lidocaine or other anesthetic agents (<xref rid="B6" ref-type="bibr">6</xref>,<xref rid="B7" ref-type="bibr">7</xref>).</p><p>A new adjuvant, dexmedetomidine (DEX) has recently attracted the attention of researchers because it is a potent &#x003b1;-2 adrenoceptor agonist with sedative and analgesic actions (<xref rid="B8" ref-type="bibr">8</xref>). In literature, DEX has been proven to be 1620 times more selective for &#x003b1;-2 receptors and, in addition, it is associated with greater hemodynamic stability when compared to other adjuvants. The drug acts by binding to presynaptic &#x003b1;-adrenoreceptors, which results in the inhibition of epinephrine release. This leads to the termination of the propagation of pain signals (<xref rid="B9" ref-type="bibr">9</xref>).</p><p>However, recent clinical trials have focused on this new drug as a possible additive to local anesthesia. Studies suggest that the combination of DEX and lidocaine increases the nerve block time and decreases the onset of action. They also suggested that this association reduced pain scores to a significantly greater extent than lidocaine alone and decreased the frequency of postoperative analgesic use compared to the control group (<xref rid="B5" ref-type="bibr">5</xref>,<xref rid="B7" ref-type="bibr">7</xref>,<xref rid="B9" ref-type="bibr">9</xref>,<xref rid="B10" ref-type="bibr">10</xref>). The anti-inflammatory potential of DEX when injected locally promotes improved postoperative pain control (<xref rid="B9" ref-type="bibr">9</xref>,<xref rid="B11" ref-type="bibr">11</xref>).</p><p>There is a need for critical analysis of the results of these studies to present more clinically relevant data on this subject. In addition, there is a dearth of systematic reviews on this topic. Therefore, the current study was aimed at carrying out a systematic review and answer the following guiding question: &#x0201c;Does the use of DEX as an additive to local anesthetics promote greater safety and efficacy compared to local anesthetics without DEX in dental procedures?&#x0201d;.</p><p>Materials and Methods</p><p>- Registry Protocol</p><p>The present study adhered to Enhancing the Quality and Transparency of Health Research (EQUATOR network) recommendations, including the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) (<xref rid="B12" ref-type="bibr">12</xref>,<xref rid="B13" ref-type="bibr">13</xref>) checklist. The methods used for this systematic review were recorded in the International Prospective Register of Systematic Reviews (PROSPERO - CRD 42022336235).</p><p>- Focused question</p><p>This systematic review was structured according to the PICO strategy: population, patients undergoing dental procedures under intraoral local anesthesia; intervention, intraoral local anesthesia with DEX; comparison, intraoral local anesthesia without DEX; main outcome, hemodynamic stability, onset, and duration of anesthesia; and additional outcome, pain during injection, postoperative pain, sedation, postoperative analgesics, blood loss, and patient satisfaction. The following focused question was proposed: &#x0201c;Does the use of DEX as an additive to local anesthetics promote greater safety and efficacy compared to local anesthetics without DEX in dental procedures?&#x0201d;</p><p>- Eligibility criteria</p><p>Studies were included based on the following criteria: randomized clinical trials and controlled clinical trials that compared local anesthetics with and without DEX in dental procedures. Pilot studies, investigations with no description of the solution anesthetics used, trials in which outcomes of interest were not available for analysis and the original values could not be retrieved after contacting the original authors, were excluded. Besides, the reports where the full-text articles were unavailable were also excluded. No data or language restrictions were applied.</p><p>- Data collection process</p><p>First, the publications registered in all databases were imported to the Endnote Reference Manager to identify duplicate entries, as illustrated in the PRISMA flow diagram (Fig. <xref rid="F1" ref-type="fig">1</xref>). The selection process was conducted independently by two authors (DAD and AJBF) to examine the titles and abstracts of all identified publications by applying the inclusion criteria (blinded process). The same two reviewers applied the exclusion criteria, independently to the other studies. This was based on reading the full text (blinded process). The following data were collected from the articles: study design, age and samples, type of anesthetic, anesthetic volume, type of anesthetic adjuvant, anesthesia site, procedure performed, heart rate, diastolic and systolic blood pressure, oxygen saturation, time of onset of anesthesia, duration of anesthesia, pain during anesthetic injection/deposition, postoperative analgesics, level of sedation, blood loss, and patient satisfaction. The data collected from the articles are presented in the Tables.</p><p>- Additional analysis</p><p>Agreement between the investigators in determining study selection from each database search was evaluated using the kappa test, assuming an accepTable threshold value of 0.8 (<xref rid="B14" ref-type="bibr">14</xref>). Disagreements at any stage were resolved by discussion and mutual consensus with a third reviewer (BCEV).</p><p>
<fig position="float" id="F1"><label>Figure 1</label><caption><p>Flow diagram describing the studies selection.</p></caption><graphic xlink:href="medoral-30-e160-g001" position="float"/></fig>
</p><p>- Search strategy</p><p>A search was conducted in the PubMed/MEDLINE, SCOPUS, Web of Science, and Clinical Trial.gov databases independently by two of the authors (DAD and AJBF) for articles published until April 30, 2023. The following terms were used in the search: (dexmedetomidine OR precedex) AND (local anesthesia OR dental anesthesia OR anesthesia infiltration OR nerve block OR nerve blockade OR levobupivacaine OR bupivacaine OR lidocaine OR lignocaine OR xylocaine OR prilocaine OR articaine OR mepivacaine OR ropivacaine) AND (dental OR dental care OR dental procedures OR dental surgical procedures OR dental surgery OR oral OR oral health OR oral procedures OR oral surgical procedures OR oral surgery OR tooth OR teeth OR impacted tooth OR impacted teeth OR third molar OR third molar surgery OR third molar extraction OR teeth extraction OR tooth extraction OR periodontitis OR periodontal disease OR periodontal surgery OR dental implants OR pulpitis OR endodontics). Any disagreements between the evaluators were resolved by a third author (BCEV) (Supplement 1).</p><p>The same authors performed a manual search for articles published in the following journals from January 2020 to June 2023: &#x0201c;Medicina Oral Patologia Oral y Cirurgia Bucal&#x0201d;, &#x0201c;International Journal of Oral and Maxillofacial Surgery&#x0201d;; &#x0201c;Journal of Oral and Maxillofacial Surgery&#x0201d;; &#x0201c;Journal of Cranio-Maxillofacial Surgery&#x0201d;; &#x0201c;British Journal of Oral and Maxillofacial Surgery&#x0201d;; &#x0201c;Journal of Clinical Anesthesia and Clinical Oral Investigations&#x0201d;. The search was also performed using ClinicalTrials.gov and the reference lists of the selected articles (gray literature) (Supplement 1).</p><p>- Risk of bias and quality assessment</p><p>The article quality was evaluated using the Cochrane Risk of Bias tool (ROB 2.0) (<xref rid="B15" ref-type="bibr">15</xref>) for RCT studies. This tool evaluates selection bias (randomization process), performance bias (effect of assignment to intervention and mean outcome), bias detection, attrition bias (missing outcome data), reporting bias (selection of the reported result), and biases from other sources (Overall Bias) (Fig. <xref rid="F2" ref-type="fig">2</xref>). CCTs studies were evaluated using the Risk of Bias in Non-randomized Studies of Interventions (ROBINS-I) (<xref rid="B12" ref-type="bibr">12</xref>) (Supplement 2).</p><p>
<fig position="float" id="F2"><label>Figure 2</label><caption><p>Assessment of the Risk Of Bias (ROB 2.0).</p></caption><graphic xlink:href="medoral-30-e160-g002" position="float"/></fig>
</p><p>- Grading the body of evidence</p><p>For the final narrative synthesis, we used the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) to assess the certainty of evidence for narrative synthesis. This system classifies the quality of evidence into high, moderate, low, and very low, according to factors that consider the study design: risk of bias, inconsistency, indirectness, imprecision, and publication bias. The evidence was further assessed for dose-response, the effect&#x02019;s magnitude, and residual confounders that could increase certainty (Supplement 3) (<xref rid="B13" ref-type="bibr">13</xref>,<xref rid="B14" ref-type="bibr">14</xref>). Studies were independently evaluated by two authors (DAD and AJBF), and agreement was reached in a consensus meeting with a third reviewer (BCEV), as required.</p><p>- Data extraction and synthesis of the results</p><p>Descriptive results were presented in the form of text, Figures, and Tables, in accordance with the PICO strategy. Data were evaluated based on the differences in mean and standard deviation between the intervention and control groups. The main and secondary outcomes were grouped and compared using an anesthetic solution (with and without DEX).</p></sec><sec><title>Results</title><p>- Literature search</p><p>A total of 560 articles were retrieved from the PubMed/Medline (n = 196), Web of Science (n =247), Scopus (n =107), and Clinical Trial.gov (n =10) electronic databases. After removing duplicates (n =116), a manual search of the journals was performed. Titles and abstracts of the articles were read, and eligibility criteria were applied. A total of 13 articles underwent further analysis, from which four were excluded after reading the entire text. The exclusion criteria included: studies with patients undergoing general anesthesia, pilot studies and studies where no response was obtained from the authors about the data.</p><p>Finally, nine articles were included in the systematic review. A flowchart of the strategic research process has been shown in (Supplement 1). The Kappa score for the included studies retrieved from the respective databases was &#x0003e; 90%. This result suggested an &#x0201c;almost perfect agreement&#x0201d; between the examiners (<xref rid="B14" ref-type="bibr">14</xref>).</p><p>- Description of the studies</p><p>In <xref rid="T1" ref-type="table">Table 1</xref>, the qualitative characteristics of the nine included studies have been outlined. They are separated by the comparison of the control group (local anesthetic) and the DEX group (local anesthetic + DEX), eight randomized clinical trials, and one controlled clinical trial. Six studies (<xref rid="B9" ref-type="bibr">9</xref>,<xref rid="B16" ref-type="bibr">16</xref>-<xref rid="B20" ref-type="bibr">20</xref>) were related to tooth extraction. Other types of intervention were not reported by the author. A total of 382 patients were included in this study. In most studies, the local anesthetic used was lidocaine (8 of 9 studies) (<xref rid="B9" ref-type="bibr">9</xref>,<xref rid="B11" ref-type="bibr">11</xref>,<xref rid="B16" ref-type="bibr">16</xref>-<xref rid="B18" ref-type="bibr">18</xref>,<xref rid="B20" ref-type="bibr">20</xref>-<xref rid="B22" ref-type="bibr">22</xref>). The anesthetic was used in varying concentrations of 0.7%, 1%, 1.8%, and 2%. Levobupivacaine (0.5%) was used in only study (<xref rid="B19" ref-type="bibr">19</xref>). Seven studies used the inferior alveolar nerve block (<xref rid="B9" ref-type="bibr">9</xref>,<xref rid="B11" ref-type="bibr">11</xref>,<xref rid="B16" ref-type="bibr">16</xref>-<xref rid="B21" ref-type="bibr">21</xref>).</p><p>In <xref rid="T2" ref-type="table">Table 2</xref>, the quantitative characteristics of the included studies have been summarized. These which were separated by group comparison. The mean time of onset of anesthesia in the control group (3.53 min) was longer than that in the DEX group (3.36 min). The mean duration of anesthesia with lidocaine in the control group (141.05 min) was lower than that in the DEX group (189.47 min). Only one study analyzed the number of pills used for postoperative analgesia, with an average of 4.04 pills in the control group and higher than the average number in the DEX group (2.12 pills) (<xref rid="B19" ref-type="bibr">19</xref>).</p><p>In <xref rid="T3" ref-type="table">Table 3</xref>, the hemodynamic parameters found in some of the included studies during the period before (between 15 and 20 minutes), and after (from 60 minutes) surgery have been summarized. The mean heart rate was lower (79.82 bpm) in the DEX group than in the control group (80.78 bpm). Diastolic blood pressure in the control group showed an increased average (76.42 mmHg) compared to the DEX group (74.75 mmHg). Likewise, systolic blood pressure showed a lower value in the DEX group (116.46 mmHg/control:121.36). Oxygen saturation remained unchanged in both the groups. The parameters of pain, sedation level, and satisfaction after treatment are shown in <xref rid="T4" ref-type="table">Table 4</xref>. According to the visual analog scale (VAS), one of the included studies (<xref rid="B19" ref-type="bibr">19</xref>) showed that patients in the DEX group had 3.46 times lower postoperative pain scores. Two studies (<xref rid="B16" ref-type="bibr">16</xref>,<xref rid="B19" ref-type="bibr">19</xref>) assessed the degree of patient satisfaction and showed that a large number of patients considered the treatment good or excellent. Two studies (<xref rid="B11" ref-type="bibr">11</xref>,<xref rid="B21" ref-type="bibr">21</xref>) used the Mackenzie and Grant Sedation Score and no differences were observed between the two evaluated groups.</p><p>- Quality assessment of the studies</p><p>Cochrane Risk-of-Bias Tools (ROB 2.0) for Randomized Trials: A low risk of bias in &#x0201c;randomization process&#x0201d; was found in most of the studies, except for two (<xref rid="B18" ref-type="bibr">18</xref>,<xref rid="B21" ref-type="bibr">21</xref>) which had a moderate risk of bias. A low risk of bias was found in all studies for &#x0201c;Effect of assignment to intervention&#x0201d;, &#x0201c;Missing outcome data&#x0201d;, and &#x0201c;Measurements of the outcome&#x0201d;. Regarding the selection of reported results&#x0201d;, a moderate risk of bias was found in all studies. Overall, the selected studies were considered to have a low risk of bias (Fig. <xref rid="F2" ref-type="fig">2</xref>).</p><p>ROBINS-I: The only study that used this tool had a low risk of bias (<xref rid="B20" ref-type="bibr">20</xref>) (Supplement 2). Regarding the certainty of evidence, there was a low strength of evidence supporting the benefits of DEX for local anesthesia in dentistry and a low degree of recommendation for its use compared with traditional anesthetics.</p><p>- Certainty of evidence rating and strength of recommendations grading</p><p>In general, the onset of anesthesia, duration of anesthesia, pain during injection, blood loss, heart rate, diastolic blood pressure, systolic blood pressure, and oxygen saturation had a very low certainty of evidence, whereas postoperative analgesics, pain, sedation, and patient satisfaction had a low certainty of evidence.</p></sec><sec><title>Discussion</title><p>Most of the included studies resulted in significant results. However, caution should be exercised when interpreting these results due to differences in assessments, little scientific strength with unclear methodologies in most of them. Although this systematic review retrieved a large number of RCTs, some data showed moderate bias, in addition to low or very low certainty of evidence. Limitations were found in the studies, including differences in dosages and reported concentrations of anesthetic solutions (1-2 mL and 0.5%-2%, respectively). Furthermore, the DEX concentration showed no standardization, ranging from 1.8 mcg to 180 mcg in the solutions (<xref rid="T1" ref-type="table">Table 1</xref>).</p><p>DEX is a promising drug, being the active dextro-isomer of medetomidine, which exhibits specific and selective &#x003b1;2-adrenoceptor agonism. Studies have shown that when used as an additive to local anesthetics, it shortens the latency period and prolongs its duration, corroborating the findings of the present study (<xref rid="T2" ref-type="table">Table 2</xref>). An important element of superiority was observed in terms of the duration time and faster onset of action in patients undergoing treatment with DEX in association with local anesthetic. The observed lower latency can be attributed to the blockade of presynaptic &#x003b1;2 receptors by DEX, which inhibits the release of norepinephrine, thereby ending the propagation of pain signals and prolonging hyperpolarization. This prevents the nerve from returning to the resting membrane potential (<xref rid="B22" ref-type="bibr">22</xref>).</p><p>The clinical action of DEX not only prolongs the duration of anesthesia, but also helps to reduce anxiety and induce sedation and analgesia (<xref rid="B8" ref-type="bibr">8</xref>). According to the parameters shown in <xref rid="T4" ref-type="table">Table 4</xref>, patients in the DEX group had considerably positive results from the point of view of postoperative pain according to the VAS (<xref rid="B19" ref-type="bibr">19</xref>). These results indicate the analgesic potency and prolonged duration of action of DEX, which can be attributed to its anti-inflammatory and local vasoconstriction effects, respectively. Studies have shown that DEX acts centrally, inhibiting the discharge of substance <italic>P</italic> by activating the &#x003b1;2 receptors at the locus coeruleus (<xref rid="B20" ref-type="bibr">20</xref>).</p><p>With respect to sedation (<xref rid="T4" ref-type="table">Table 4</xref>), two studies (<xref rid="B11" ref-type="bibr">11</xref>,<xref rid="B21" ref-type="bibr">21</xref>) presented results using the Mackenzie and Grant Sedation Scale. However, no differences were observed between the means of the evaluated groups. This result differs from those reported in literature (<xref rid="B9" ref-type="bibr">9</xref>,<xref rid="B10" ref-type="bibr">10</xref>,<xref rid="B20" ref-type="bibr">20</xref>), considering that DEX is a systemic sedative agent. Due to the limited number of studies and the studies being from the same author, caution should be exercised when interpreting these results.</p><p>In addition, hemodynamic stability seemed to be a positive factor in patients in the DEX group. According to the studies included in this review (<xref rid="T3" ref-type="table">Table 3</xref>), heart rate and systolic and diastolic blood pressure were lower &#x0200b;&#x0200b;in the intraoperative period, reducing the chance of developing postoperative complications such as hemorrhages. This corroborated with occurrence of physiological processes related to hemostasis. When the blood pressure values are lower, the risk of bleeding in the intraoperative period is lower and lower is the rate of complications related to hemorrhage in the postoperative period. As observed in <xref rid="T2" ref-type="table">Table 2</xref>, one of the studies (<xref rid="B20" ref-type="bibr">20</xref>) showed 20% less bleeding in patients who used the solution with DEX. However, it is important to note that only one study evaluated the blood loss variable, which becomes an important limitation in the analysis of the outcome. Maintenance of oxygen saturation was also observed in both groups (<xref rid="T3" ref-type="table">Table 3</xref>). The administration of DEX did not cause respiratory depression, thereby not affecting the respiratory system or tissue oxygen perfusion.</p><p>Local anesthetics have inverted kinetics: they first exert a local action on the tissue and then are distributed and biotransformed in the body, unlike systemic use. Therefore, the objective of DEX as an additive is to evaluate the possible benefits associated with the local anesthetic already demonstrated in the primary studies.</p><p>In local anesthetics currently used in dentistry, vasoconstrictors are added, such as epinephrine, which in medicine is commonly found in 1:1000 ampoules. The concentrations used in dental anesthetic tubes are normally 1:100,000 or 1:200,000, which guarantee greater safety and allow for cautious use. DEX as an adjuvant to local anesthetics has the same objective. Studies are being carried out to find an ideal concentration that combines efficacy and safety for use in Dentistry. Its concentration is not the same as that used in medicine, as the purpose is different. In Dentistry, they are not being studied for the purpose of conscious sedation and general anesthesia.</p><p>Information on side effects as an anesthetic adjuvant is scarce or not observed, as the quantity used in studies is limited, with no possibility of overdose. We believe that as new studies emerge, complications can be better understood. Thus, the present work does not aim to support the immediate use of DEX as an additive, but to bring the existing results in the literature and also to support future studies, so that it may become an alternative to conventional anesthetics with vasoconstrictors.</p><p>Due to the heterogeneity in the types, dosages, and concentrations of local anesthetics, it was not possible to perform a meta-analysis in this systematic review. Therefore, qualitative analysis of the data was conducted. Despite this, DEX has important properties and potential for future studies in the field of Local Anesthesiology in Dentistry.</p></sec></body><back><ack><title>Acknowledgement</title><p>Editage has provided an English editing service for the manuscript.</p></ack><sec><title>Funding</title><p>None.</p></sec><sec sec-type="COI-statement"><title>Conflict of interest</title><p>The authors declare no conflict of interest, financial or otherwise.</p></sec><notes><title>Institutional Review Board Statement</title><p>Not applicable</p></notes><notes><title>Author Contributions</title><p> Dem&#x000f3;stenes Alves Diniz: Writing review and editing, Writing original draft, Methodology, Investigation, Data curation.
Arthur Jos&#x000e9; Barbosa de Fran&#x000e7;a: Writing review and editing, Writing original draft, Methodology, Investigation, Data curation, Conceptualization.
Jos&#x000e9; Rodrigues Laureano Filho: Investigation, Data curation, Supervision.
Eduardo Piza Pellizzer: Writing review and editing, Supervision, Methodology, Formal analysis.
Sandra L&#x000fa;cia Dantas de Moraes: Writing review and editing, Supervision, Methodology, Formal analysis.
Belmiro Cavalcanti do Egito Vasconcelos: Writing review and editing, Supervision, Methodology, Project administration.
Final approval of manuscript: All authors.</p></notes><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>J</given-names></name><name><surname>Min</surname><given-names>S</given-names></name></person-group><article-title>Postoperative pain management in the postanesthesia care unit: an update</article-title><source>J Pain Res</source><year>2017</year><volume>10</volume><fpage>2687</fpage><lpage>98</lpage><pub-id pub-id-type="pmid">29180895</pub-id>
</element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jastak</surname><given-names>JT</given-names></name><name><surname>Yagiela</surname><given-names>JA</given-names></name></person-group><article-title>Vasoconstrictors and local anesthesia: a review and rationale for use</article-title><source>J Am Dent Assoc</source><year>1983</year><volume>107</volume><fpage>623</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">6355236</pub-id>
</element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Picozzi</surname><given-names>A</given-names></name><name><surname>Neidle</surname><given-names>EA</given-names></name></person-group><article-title>A survey of the use of selected drugs in dental practice</article-title><source>J Am Dent Assoc</source><year>1981</year><volume>103</volume><fpage>597</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">6116727</pub-id>
</element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanazi</surname><given-names>GE</given-names></name><name><surname>Aouad</surname><given-names>MT</given-names></name><name><surname>Jabbour-Khoury</surname><given-names>SI</given-names></name><name><surname>Al Jazzar</surname><given-names>MD</given-names></name><name><surname>Alameddine</surname><given-names>MM</given-names></name><name><surname>Al-Yaman</surname><given-names>R</given-names></name></person-group><article-title>Effect of low-dose dexmedetomidine or clonidine on the characteristics of bupivacaine spinal block</article-title><source>Acta Anaesthesiol Scand</source><year>2006</year><volume>50</volume><fpage>222</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">16430546</pub-id>
</element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calasans-Maia</surname><given-names>JA</given-names></name><name><surname>Zapata-Sudo</surname><given-names>G</given-names></name><name><surname>Sudo</surname><given-names>RT</given-names></name></person-group><article-title>Dexmedetomidine prolongs spinal anaesthesia induced by levobupivacaine 0.5% in guinea-pigs</article-title><source>J Pharm Pharmacol</source><year>2005</year><volume>57</volume><fpage>1415</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">16259773</pub-id>
</element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eledjam</surname><given-names>JJ</given-names></name><name><surname>Deschodtt</surname><given-names>J</given-names></name><name><surname>Viel</surname><given-names>EJ</given-names></name><name><surname>Lubrano</surname><given-names>JF</given-names></name><name><surname>Charavel</surname><given-names>P</given-names></name><name><surname>Fran&#x000e7;oise</surname><given-names>d'Athis</given-names></name></person-group><article-title>Brachial plexus block with bupivacaine: effects of added alpha-adrenergic agonists: comparison between clonidine and epinephrine</article-title><source>Can J Anaesth</source><year>1991</year><volume>38</volume><fpage>870</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">1742820</pub-id>
</element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdallah</surname><given-names>FW</given-names></name><name><surname>Brull</surname><given-names>R</given-names></name></person-group><article-title>Facilitatory effects of perineural dexmedetomidine on neuraxial and peripheral nerve block: a systematic review and meta-analysis</article-title><source>Br J Anaesth</source><year>2013</year><volume>110</volume><fpage>915</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">23587874</pub-id>
</element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshitomi</surname><given-names>T</given-names></name><name><surname>Kohjitani</surname><given-names>A</given-names></name><name><surname>Maeda</surname><given-names>S</given-names></name><name><surname>Higuchi</surname><given-names>H</given-names></name><name><surname>Shimada</surname><given-names>M</given-names></name><name><surname>Miyawaki</surname><given-names>T</given-names></name></person-group><article-title>Dexmedetomidine enhances the local anesthetic action of lidocaine via an &#x003b1;-2a adrenoceptor</article-title><source>Anesth Analg</source><year>2008</year><volume>107</volume><fpage>96</fpage><lpage>101</lpage><pub-id pub-id-type="pmid">18635472</pub-id>
</element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>V</given-names></name><name><surname>Thepra</surname><given-names>M</given-names></name><name><surname>Kirti</surname><given-names>S</given-names></name><name><surname>Kumar</surname><given-names>P</given-names></name><name><surname>Priya</surname><given-names>K</given-names></name></person-group><article-title>Dexmedetomidine as an additive to Local anesthesia: a step to development in dentistry</article-title><source>J Oral Maxillofac Surg</source><year>2018</year><volume>76</volume><fpage>2091.e1</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">29964002</pub-id>
</element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vahedi</surname><given-names>Z</given-names></name><name><surname>Moshari</surname><given-names>A</given-names></name><name><surname>Moshari</surname><given-names>M</given-names></name></person-group><article-title>Efficacy of adding dexmedetomidine to lidocaine to enhance inferior alveolar nerve block in patients with asymptomatic irreversible pulpitis: double-blind randomized clinical trial</article-title><source>Clin Oral Investig</source><year>2022</year><volume>26</volume><fpage>4727</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">35267097</pub-id>
</element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ouchi</surname><given-names>K</given-names></name><name><surname>Sugiyama</surname><given-names>K</given-names></name></person-group><article-title>Dexmedetomidine dose dependently enhances the local anesthetic action of lidocaine in inferior alveolar nerve block: a randomized double-blind study</article-title><source>Reg Anesth Pain Med</source><year>2016</year><volume>41</volume><fpage>348</fpage><lpage>55</lpage><pub-id pub-id-type="pmid">27015544</pub-id>
</element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sterne</surname><given-names>JA</given-names></name><name><surname>Hern&#x000e1;n</surname><given-names>MA</given-names></name><name><surname>Reeves</surname><given-names>BC</given-names></name><name><surname>Savovi&#x00107;</surname><given-names>J</given-names></name><name><surname>Berkman</surname><given-names>ND</given-names></name><name><surname>Viswanathan</surname><given-names>M</given-names></name></person-group><article-title>Robins-i: a tool for assessing risk of bias in non-randomised studies of interventions</article-title><source>BMJ (Online)</source><year>2016</year><volume>355</volume><fpage>i4919</fpage><pub-id pub-id-type="pmid">27733354</pub-id>
</element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guyatt</surname><given-names>GH</given-names></name><name><surname>Oxman</surname><given-names>AD</given-names></name><name><surname>Sch&#x000fc;nemann</surname><given-names>HJ</given-names></name><name><surname>Tugwell</surname><given-names>P</given-names></name><name><surname>Knottnerus</surname><given-names>A</given-names></name></person-group><article-title>Grade guidelines: a new series of articles in the journal of clinical epidemiology</article-title><source>J Clin Epidemiol</source><year>2011</year><volume>64</volume><fpage>380</fpage><lpage>2</lpage><pub-id pub-id-type="pmid">21185693</pub-id>
</element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guyatt</surname><given-names>GH</given-names></name><name><surname>Oxman</surname><given-names>AD</given-names></name><name><surname>Vist</surname><given-names>GE</given-names></name><name><surname>Kunz</surname><given-names>R</given-names></name><name><surname>Falck-Ytter</surname><given-names>Y</given-names></name><name><surname>Alonso-Coello</surname><given-names>P</given-names></name></person-group><article-title>Grade: an emerging consensus on rating quality of evidence and strength of recommendations</article-title><source>BMJ</source><year>2008</year><volume>336</volume><fpage>924</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">18436948</pub-id>
</element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Higgins</surname><given-names>JPT</given-names></name><name><surname>Altman</surname><given-names>DG</given-names></name><name><surname>G&#x000f8;tzsche</surname><given-names>PC</given-names></name><name><surname>J&#x000fc;ni</surname><given-names>P</given-names></name><name><surname>Moher</surname><given-names>D</given-names></name><name><surname>Oxman</surname><given-names>AD</given-names></name></person-group><article-title>The Cochrane Collaboration's tool for assessing risk of bias in randomised trials</article-title><source>BMJ (Online)</source><year>2011</year><volume>343</volume><fpage>d5928</fpage><pub-id pub-id-type="pmid">22008217</pub-id>
</element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alizargar</surname><given-names>J</given-names></name><name><surname>Etemadi Sh</surname><given-names>M</given-names></name><name><surname>Kaviani</surname><given-names>N</given-names></name><name><surname>Wu</surname><given-names>SFV</given-names></name><name><surname>Jafarzadeh</surname><given-names>K</given-names></name><name><surname>Ranjbarian</surname><given-names>P</given-names></name></person-group><article-title>Injection of lidocaine alone versus lidocaine plus dexmedetomidine in impacted third molar extraction surgery, a double-blind randomized control trial for postoperative pain evaluation</article-title><source>Pain Res Manag</source><year>2021</year><volume>2021</volume><fpage>6623792</fpage><pub-id pub-id-type="pmid">33574974</pub-id>
</element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khandaitkar</surname><given-names>S</given-names></name><name><surname>Kolte</surname><given-names>V</given-names></name><name><surname>Shenoi</surname><given-names>SR</given-names></name><name><surname>Budhraja</surname><given-names>N</given-names></name></person-group><article-title>A clinical study to determine the efficacy of 7ppm dexmedetomidine as an adjuvant to 2% lignocaine in infraorbital nerve block</article-title><source>Br J Oral Maxillofac Surg</source><year>2016</year><volume>54</volume><fpage>997</fpage><lpage>1000</lpage><pub-id pub-id-type="pmid">27522312</pub-id>
</element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nalawade</surname><given-names>SH</given-names></name><name><surname>Nilesh</surname><given-names>K</given-names></name><name><surname>Mounesh Kumar</surname><given-names>CD</given-names></name><name><surname>Punde</surname><given-names>PA</given-names></name><name><surname>Patil</surname><given-names>PB</given-names></name></person-group><article-title>A clinical comparative study of dexmedetomidine as an adjuvant to 2% plain lignocaine and 2% lignocaine with 1:200.000 adrenaline as local anesthetic agents for surgical removal of impacted mandibular third molars</article-title><source>Natl J Maxillofac Surg</source><year>2021</year><volume>12</volume><fpage>255</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">34483586</pub-id>
</element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patil</surname><given-names>SM</given-names></name><name><surname>Jadhav</surname><given-names>A</given-names></name><name><surname>Bhola</surname><given-names>N</given-names></name><name><surname>Hingnikar</surname><given-names>P</given-names></name><name><surname>Kshirsagar</surname><given-names>K</given-names></name><name><surname>Patil</surname><given-names>D</given-names></name></person-group><article-title>Does dexmedetomidine combined with levobupivacaine in inferior alveolar nerve blocks among patients undergoing impacted third molar surgery control postoperative morbidity?</article-title><source>J Dent Anesth Pain Med</source><year>2022</year><volume>22</volume><fpage>145</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">35449786</pub-id>
</element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Priyaranjan</surname><given-names>Rohit</given-names></name><name><surname>Dcruz</surname><given-names>TM</given-names></name><name><surname>Patel</surname><given-names>C</given-names></name><name><surname>Masih</surname><given-names>A</given-names></name><name><surname>Shaik</surname><given-names>I</given-names></name></person-group><article-title>A comparative study evaluating the efficacy of lignocaine and dexmedetomidine with lignocaine and adrenaline in third molar surgery</article-title><source>J Maxillofac Oral Surg</source><year>2020</year><volume>21</volume><fpage>634</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">35712398</pub-id>
</element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ouchi</surname><given-names>K</given-names></name></person-group><article-title>Dexmedetomidine 2 ppm is appropriate for the enhancement effect of local anesthetic action of lidocaine in inferior alveolar nerve block: a preliminary, randomized cross-over study</article-title><source>Clin J Pain</source><year>2020</year><volume>36</volume><fpage>618</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">32398441</pub-id>
</element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamane</surname><given-names>A</given-names></name><name><surname>Higuchi</surname><given-names>H</given-names></name><name><surname>Tomoyasu</surname><given-names>Y</given-names></name><name><surname>Ishii-Maruhama</surname><given-names>M</given-names></name><name><surname>Maeda</surname><given-names>S</given-names></name><name><surname>Miyawaki</surname><given-names>T</given-names></name></person-group><article-title>Effect of dexmedetomidine injected into the oral mucosa in combination with lidocaine on local anesthetic potency in humans: a crossover double-blind study</article-title><source>J Oral Maxillofac Surg</source><year>2015</year><volume>73</volume><fpage>616</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">25544294</pub-id>
</element-citation></ref></ref-list></back><floats-group><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>General data of the studies, anesthetics with and without DEX, procedures performed and anesthesia site.</p></caption><table frame="border" rules="all" width="100%"><thead><tr><th rowspan="1" colspan="1">Author/year of publication</th><th rowspan="1" colspan="1">Study
design</th><th rowspan="1" colspan="1">Age/sample</th><th rowspan="1" colspan="1">Volume/Local Anesthetic (control)</th><th rowspan="1" colspan="1">Volume/Local Anesthetic (DEX)</th><th rowspan="1" colspan="1">Procedure performed</th><th rowspan="1" colspan="1">Anesthesia site</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Yamane, 2015</td><td align="center" valign="middle" rowspan="1" colspan="1">RCT</td><td align="center" valign="middle" rowspan="1" colspan="1">25-32 / 20</td><td align="center" valign="middle" rowspan="1" colspan="1">1ml Lidocaine 0.7%*</td><td align="center" valign="middle" rowspan="1" colspan="1">1ml Lidocaine 0.7% + 1mmol/L DEX*</td><td align="center" valign="middle" rowspan="1" colspan="1">NR</td><td align="center" valign="middle" rowspan="1" colspan="1">Infiltration (anterior teeth)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Khandaitkar, 2016</td><td align="center" valign="middle" rowspan="1" colspan="1">RCT</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e; 18 / 90</td><td align="center" valign="middle" rowspan="1" colspan="1">2ml Lidocaine 2% + 0.14ml SS</td><td align="center" valign="middle" rowspan="1" colspan="1">2ml Lidocaine 2% + 0.14ml DEX</td><td align="center" valign="middle" rowspan="1" colspan="1">Extraction</td><td align="center" valign="middle" rowspan="1" colspan="1">IONB</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ouchi, 2016</td><td align="center" valign="middle" rowspan="1" colspan="1">RCT</td><td align="center" valign="middle" rowspan="1" colspan="1">21-32 / 18</td><td align="center" valign="middle" rowspan="1" colspan="1">Lidocaine 1% + ep. 1:80.000</td><td align="center" valign="middle" rowspan="1" colspan="1">1. Lidocaine 1% + 2.5ppm DEX
2. Lidocaine 1% + 5.0ppm DEX
3. Lidocaine 1% + 7.5ppm DEX</td><td align="center" valign="middle" rowspan="1" colspan="1">NR</td><td align="center" valign="middle" rowspan="1" colspan="1">IANB</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Singh, 2018</td><td align="center" valign="middle" rowspan="1" colspan="1">RCT</td><td align="center" valign="middle" rowspan="1" colspan="1">10-25 / 25</td><td align="center" valign="middle" rowspan="1" colspan="1">Lidocaine 2% + ep. 1:200.000</td><td align="center" valign="middle" rowspan="1" colspan="1">Lidocaine 2% + 30mg DEX</td><td align="center" valign="middle" rowspan="1" colspan="1">Extraction</td><td align="center" valign="middle" rowspan="1" colspan="1">IONB, IANB, GP, LNB</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Priyaranjan, 2020</td><td align="center" valign="middle" rowspan="1" colspan="1">RCT</td><td align="center" valign="middle" rowspan="1" colspan="1">20-30 / 40</td><td align="center" valign="middle" rowspan="1" colspan="1">Lidocaine 2% + ep. 1:80.000</td><td align="center" valign="middle" rowspan="1" colspan="1">Lidocaine 2% + 1&#x003bc;/ml DEX</td><td align="center" valign="middle" rowspan="1" colspan="1">Extraction of third molar</td><td align="center" valign="middle" rowspan="1" colspan="1">IANB, LNB</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ouchi, 2020</td><td align="center" valign="middle" rowspan="1" colspan="1">RCT</td><td align="center" valign="middle" rowspan="1" colspan="1">NR / 19</td><td align="center" valign="middle" rowspan="1" colspan="1">Lidocaine 1,8% + ep. 1:80.000</td><td align="center" valign="middle" rowspan="1" colspan="1">1. 1.8ml Lidocaine 1.8% + 1.0ppm DEX
2. 1.8ml Lidocaine 1.8% + 2.0ppm DEX</td><td align="center" valign="middle" rowspan="1" colspan="1">NR</td><td align="center" valign="middle" rowspan="1" colspan="1">IANB</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Alizargar, 2021</td><td align="center" valign="middle" rowspan="1" colspan="1">RCT</td><td align="center" valign="middle" rowspan="1" colspan="1">18-40 / 40</td><td align="center" valign="middle" rowspan="1" colspan="1">Lidocaine</td><td align="center" valign="middle" rowspan="1" colspan="1">Lidocaine + 15ml DEX</td><td align="center" valign="middle" rowspan="1" colspan="1">Extraction of third molar</td><td align="center" valign="middle" rowspan="1" colspan="1">IANB</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Nalawade, 2021</td><td align="center" valign="middle" rowspan="1" colspan="1">RCT</td><td align="center" valign="middle" rowspan="1" colspan="1">18-35 / 80</td><td align="center" valign="middle" rowspan="1" colspan="1">Lidocaine 2% + ep. 1:200.000</td><td align="center" valign="middle" rowspan="1" colspan="1">Lidocaine 2% + DEX 1mcg/ml of Lidocaine</td><td align="center" valign="middle" rowspan="1" colspan="1">Extraction of third molar</td><td align="center" valign="middle" rowspan="1" colspan="1">IANB, BNB</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Patil, 2022</td><td align="center" valign="middle" rowspan="1" colspan="1">RCT</td><td align="center" valign="middle" rowspan="1" colspan="1">22-48 / 50</td><td align="center" valign="middle" rowspan="1" colspan="1">1.8ml Levobupivacaine 0.5% + 0.2ml SS</td><td align="center" valign="middle" rowspan="1" colspan="1">1.8ml Levobupivacaine 0.5% + 0.2ml DEX</td><td align="center" valign="middle" rowspan="1" colspan="1">Extraction of third molar</td><td align="center" valign="middle" rowspan="1" colspan="1">IANB</td></tr></tbody></table><table-wrap-foot><fn><p>DEX: Dexmedetomidine, RCT: Randomized clinical trial, CCT: Controlled clinical trial, ml: milliliters, mg: milligrams, %: percent, mmol/L: Milimol per liter, ep: epinephrine, SS: Saline Solution, ppm: parts per million, mcg: Microgram, &#x003bc;: Micro, IONB: Infraorbital nerve block, IANB: Inferior alveolar nerve block, LNB: Lingual nerve block, BNB: Buccal nerve block, GP: Greater palatine; NR: not reported; *at a final concentration of 0.7%.
</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Onset time and duration of anesthesia, injection pain, use of analgesics and blood loss.</p></caption><table frame="border" rules="all" width="100%"><thead><tr><th rowspan="2" colspan="1">Author/
year of publication</th><th colspan="2" rowspan="1">Onset time</th><th colspan="2" rowspan="1">Duration</th><th colspan="4" rowspan="1">Pain during injection</th><th colspan="2" rowspan="1">Postoperative analgesics</th><th colspan="2" rowspan="1">Blood loss</th></tr><tr><th rowspan="1" colspan="1">C</th><th rowspan="1" colspan="1">I</th><th rowspan="1" colspan="1">C</th><th rowspan="1" colspan="1">I</th><th rowspan="1" colspan="1">C</th><th colspan="3" rowspan="1">I</th><th rowspan="1" colspan="1">C</th><th rowspan="1" colspan="1">I</th><th rowspan="1" colspan="1">C</th><th rowspan="1" colspan="1">I</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Khandaitkar, 2016</td><td align="center" valign="middle" rowspan="1" colspan="1">261.67 s</td><td align="center" valign="middle" rowspan="1" colspan="1">185 s</td><td align="center" valign="middle" rowspan="1" colspan="1">70.43 s</td><td align="center" valign="middle" rowspan="1" colspan="1">124.87 s</td><td align="center" valign="middle" rowspan="1" colspan="1">NR</td><td colspan="3" align="center" valign="middle" rowspan="1">NR</td><td align="center" valign="middle" rowspan="1" colspan="1">NR</td><td align="center" valign="middle" rowspan="1" colspan="1">NR</td><td align="center" valign="middle" rowspan="1" colspan="1">NR</td><td align="center" valign="middle" rowspan="1" colspan="1">NR</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ouchi, 2016</td><td align="center" valign="middle" rowspan="1" colspan="1">40020 s</td><td align="center" valign="middle" rowspan="1" colspan="1">Dex 2.5: 333.6 s
Dex 5.0:
267 s
Dex 7.5: 250.2 s</td><td align="center" valign="middle" rowspan="1" colspan="1">131220 s</td><td align="center" valign="middle" rowspan="1" colspan="1">Dex 2.5: 142380 s
Dex 5.0: 157440 s
Dex 7.5: 173460 s</td><td align="center" valign="middle" rowspan="1" colspan="1">PL: 11
MI: 4
MO: 2
SE: 1</td><td align="center" valign="middle" rowspan="1" colspan="1">Dex 2.5
PL: 7
MI: 6
MO: 5
SE: 0</td><td align="center" valign="middle" rowspan="1" colspan="1">Dex 5.0
PL: 6
MI: 6
MO: 6
SE: 0</td><td align="center" valign="middle" rowspan="1" colspan="1">Dex 7.5
PL: 7
MI: 6
MO: 5
SE: 0</td><td align="center" valign="middle" rowspan="1" colspan="1">NR</td><td align="center" valign="middle" rowspan="1" colspan="1">NR</td><td align="center" valign="middle" rowspan="1" colspan="1">NR</td><td align="center" valign="middle" rowspan="1" colspan="1">NR</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Singh, 2018</td><td align="center" valign="middle" rowspan="1" colspan="1">Mand:
141 s</td><td align="center" valign="middle" rowspan="1" colspan="1">Mand:
113 s</td><td align="center" valign="middle" rowspan="1" colspan="1">Mand:
9420 s</td><td align="center" valign="middle" rowspan="1" colspan="1">Mand:
10440 s</td><td align="center" valign="middle" rowspan="1" colspan="1">NR</td><td colspan="3" align="center" valign="middle" rowspan="1">NR</td><td align="center" valign="middle" rowspan="1" colspan="1">NR</td><td align="center" valign="middle" rowspan="1" colspan="1">NR</td><td align="center" valign="middle" rowspan="1" colspan="1">NR</td><td align="center" valign="middle" rowspan="1" colspan="1">NR</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Priyaranjan, 2020</td><td align="center" valign="middle" rowspan="1" colspan="1">95 s</td><td align="center" valign="middle" rowspan="1" colspan="1">138 s</td><td align="center" valign="middle" rowspan="1" colspan="1">4200 s</td><td align="center" valign="middle" rowspan="1" colspan="1">7920 s</td><td align="center" valign="middle" rowspan="1" colspan="1">NR</td><td colspan="3" align="center" valign="middle" rowspan="1">NR</td><td align="center" valign="middle" rowspan="1" colspan="1">NR</td><td align="center" valign="middle" rowspan="1" colspan="1">NR</td><td align="center" valign="middle" rowspan="1" colspan="1">10
ml</td><td align="center" valign="middle" rowspan="1" colspan="1">8
ml</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ouchi, 2020</td><td align="center" valign="middle" rowspan="1" colspan="1">2460 s</td><td align="center" valign="middle" rowspan="1" colspan="1">Dex 1.0: 2580 s
Dex 2.0: 2760 s</td><td align="center" valign="middle" rowspan="1" colspan="1">147300 s</td><td align="center" valign="middle" rowspan="1" colspan="1">Dex 1.0: 130620 s
Dex 2.0: 142860 s</td><td align="center" valign="middle" rowspan="1" colspan="1">PL: 0
MI: 11
MO: 8
SE: 0</td><td align="center" valign="middle" rowspan="1" colspan="1">Dex 1.0
PL: 1
MI: 10
MO: 7
SE: 1</td><td colspan="2" align="center" valign="middle" rowspan="1">Dex 2.0
PL: 1
MI: 9
MO: 9
SE: 0</td><td align="center" valign="middle" rowspan="1" colspan="1">NR</td><td align="center" valign="middle" rowspan="1" colspan="1">NR</td><td align="center" valign="middle" rowspan="1" colspan="1">NR</td><td align="center" valign="middle" rowspan="1" colspan="1">NR</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Nalawade, 2021</td><td align="center" valign="middle" rowspan="1" colspan="1">11160 s</td><td align="center" valign="middle" rowspan="1" colspan="1">5340 s</td><td align="center" valign="middle" rowspan="1" colspan="1">46020 s</td><td align="center" valign="middle" rowspan="1" colspan="1">59040 s</td><td align="center" valign="middle" rowspan="1" colspan="1">NR</td><td colspan="3" align="center" valign="middle" rowspan="1">NR</td><td align="center" valign="middle" rowspan="1" colspan="1">NR</td><td align="center" valign="middle" rowspan="1" colspan="1">NR</td><td align="center" valign="middle" rowspan="1" colspan="1">NR</td><td align="center" valign="middle" rowspan="1" colspan="1">NR</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Patil, 2022</td><td align="center" valign="middle" rowspan="1" colspan="1">203.6 s</td><td align="center" valign="middle" rowspan="1" colspan="1">119.9 s</td><td align="center" valign="middle" rowspan="1" colspan="1">292320 s</td><td align="center" valign="middle" rowspan="1" colspan="1">465840 s</td><td align="center" valign="middle" rowspan="1" colspan="1">NR</td><td colspan="3" align="center" valign="middle" rowspan="1">NR</td><td align="center" valign="middle" rowspan="1" colspan="1">4.04
ps</td><td align="center" valign="middle" rowspan="1" colspan="1">2.12
ps</td><td align="center" valign="middle" rowspan="1" colspan="1">NR</td><td align="center" valign="middle" rowspan="1" colspan="1">NR</td></tr></tbody></table><table-wrap-foot><fn><p>C: control, DEX: dexmedetomidine, I: Intervention, Mand: mandible, MI: mild, ml: milliliters, MO: moderate, NR: not reported, PL: painless, ps: pills, s: seconds, SE: severe.
</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="T3"><label>Table 3</label><caption><p>Hemodynamic data from the included studies.</p></caption><table frame="border" rules="all" width="100%"><thead><tr><th colspan="3" rowspan="1">Author/year of publication</th><th rowspan="1" colspan="1">Yamane, 2015</th><th rowspan="1" colspan="1">Singh,
2018</th><th rowspan="1" colspan="1">Priyaranjan, 2020</th><th rowspan="1" colspan="1">Alizargar, 2021</th><th rowspan="1" colspan="1">Patil, 2022</th><th rowspan="1" colspan="1">Nalawade, 2021</th></tr></thead><tbody><tr><td rowspan="6" align="center" valign="middle" colspan="1">Heart rate (bpm)</td><td rowspan="3" align="center" valign="middle" colspan="1">Control</td><td align="center" valign="middle" rowspan="1" colspan="1">Pre</td><td align="center" valign="middle" rowspan="1" colspan="1">69.3</td><td align="center" valign="middle" rowspan="1" colspan="1">78.9</td><td align="center" valign="middle" rowspan="1" colspan="1">84</td><td align="center" valign="middle" rowspan="1" colspan="1">84.4</td><td align="center" valign="middle" rowspan="1" colspan="1">74.24</td><td align="center" valign="middle" rowspan="1" colspan="1">76.58</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Trans</td><td align="center" valign="middle" rowspan="1" colspan="1">70.1</td><td align="center" valign="middle" rowspan="1" colspan="1">97.2</td><td align="center" valign="middle" rowspan="1" colspan="1">97</td><td align="center" valign="middle" rowspan="1" colspan="1">84.95</td><td align="center" valign="middle" rowspan="1" colspan="1">75.36</td><td align="center" valign="middle" rowspan="1" colspan="1">79.25</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Post</td><td align="center" valign="middle" rowspan="1" colspan="1">66.8</td><td align="center" valign="middle" rowspan="1" colspan="1">82.8</td><td align="center" valign="middle" rowspan="1" colspan="1">85</td><td align="center" valign="middle" rowspan="1" colspan="1">84.55</td><td align="center" valign="middle" rowspan="1" colspan="1">76.8</td><td align="center" valign="middle" rowspan="1" colspan="1">79.1</td></tr><tr><td rowspan="3" align="center" valign="middle" colspan="1">Intervention</td><td align="center" valign="middle" rowspan="1" colspan="1">Pre</td><td align="center" valign="middle" rowspan="1" colspan="1">71.9</td><td align="center" valign="middle" rowspan="1" colspan="1">81</td><td align="center" valign="middle" rowspan="1" colspan="1">84</td><td align="center" valign="middle" rowspan="1" colspan="1">86.75</td><td align="center" valign="middle" rowspan="1" colspan="1">75.2</td><td align="center" valign="middle" rowspan="1" colspan="1">79.7</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Trans</td><td align="center" valign="middle" rowspan="1" colspan="1">71.1</td><td align="center" valign="middle" rowspan="1" colspan="1">94.6</td><td align="center" valign="middle" rowspan="1" colspan="1">73</td><td align="center" valign="middle" rowspan="1" colspan="1">90.50</td><td align="center" valign="middle" rowspan="1" colspan="1">73.84</td><td align="center" valign="middle" rowspan="1" colspan="1">78.9</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Post</td><td align="center" valign="middle" rowspan="1" colspan="1">71.7</td><td align="center" valign="middle" rowspan="1" colspan="1">86.2</td><td align="center" valign="middle" rowspan="1" colspan="1">83</td><td align="center" valign="middle" rowspan="1" colspan="1">89.55</td><td align="center" valign="middle" rowspan="1" colspan="1">77.68</td><td align="center" valign="middle" rowspan="1" colspan="1">77.13</td></tr><tr><td rowspan="6" align="center" valign="middle" colspan="1">Diastolic blood pressure (mmHg)</td><td rowspan="3" align="center" valign="middle" colspan="1">Control</td><td align="center" valign="middle" rowspan="1" colspan="1">Pre</td><td align="center" valign="middle" rowspan="1" colspan="1">63.3</td><td align="center" valign="middle" rowspan="1" colspan="1">71.1</td><td align="center" valign="middle" rowspan="1" colspan="1">81</td><td align="center" valign="middle" rowspan="1" colspan="1">72</td><td align="center" valign="middle" rowspan="1" colspan="1">74.04</td><td align="center" valign="middle" rowspan="1" colspan="1">81.13</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Trans</td><td align="center" valign="middle" rowspan="1" colspan="1">66.5</td><td align="center" valign="middle" rowspan="1" colspan="1">70.4</td><td align="center" valign="middle" rowspan="1" colspan="1">82</td><td align="center" valign="middle" rowspan="1" colspan="1">74.5</td><td align="center" valign="middle" rowspan="1" colspan="1">74.48</td><td align="center" valign="middle" rowspan="1" colspan="1">82.25</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Post</td><td align="center" valign="middle" rowspan="1" colspan="1">66.1</td><td align="center" valign="middle" rowspan="1" colspan="1">70.4</td><td align="center" valign="middle" rowspan="1" colspan="1">80</td><td align="center" valign="middle" rowspan="1" colspan="1">73</td><td align="center" valign="middle" rowspan="1" colspan="1">73.04</td><td align="center" valign="middle" rowspan="1" colspan="1">83.5</td></tr><tr><td rowspan="3" align="center" valign="middle" colspan="1">Intervention</td><td align="center" valign="middle" rowspan="1" colspan="1">Pre</td><td align="center" valign="middle" rowspan="1" colspan="1">65.8</td><td align="center" valign="middle" rowspan="1" colspan="1">71.6</td><td align="center" valign="middle" rowspan="1" colspan="1">81</td><td align="center" valign="middle" rowspan="1" colspan="1">75.5</td><td align="center" valign="middle" rowspan="1" colspan="1">75.36</td><td align="center" valign="middle" rowspan="1" colspan="1">81.75</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Trans</td><td align="center" valign="middle" rowspan="1" colspan="1">67.6</td><td align="center" valign="middle" rowspan="1" colspan="1">70.5</td><td align="center" valign="middle" rowspan="1" colspan="1">74</td><td align="center" valign="middle" rowspan="1" colspan="1">77</td><td align="center" valign="middle" rowspan="1" colspan="1">73.12</td><td align="center" valign="middle" rowspan="1" colspan="1">80.75</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Post</td><td align="center" valign="middle" rowspan="1" colspan="1">69.2</td><td align="center" valign="middle" rowspan="1" colspan="1">70.5</td><td align="center" valign="middle" rowspan="1" colspan="1">80</td><td align="center" valign="middle" rowspan="1" colspan="1">75</td><td align="center" valign="middle" rowspan="1" colspan="1">71.84</td><td align="center" valign="middle" rowspan="1" colspan="1">81.25</td></tr><tr><td rowspan="6" align="center" valign="middle" colspan="1">Systolic
blood pressure (mmHg)</td><td rowspan="3" align="center" valign="middle" colspan="1">Control</td><td align="center" valign="middle" rowspan="1" colspan="1">Pre</td><td align="center" valign="middle" rowspan="1" colspan="1">114.4</td><td align="center" valign="middle" rowspan="1" colspan="1">117.5</td><td align="center" valign="middle" rowspan="1" colspan="1">122</td><td rowspan="6" align="center" valign="middle" colspan="1">NR</td><td align="center" valign="middle" rowspan="1" colspan="1">113.36</td><td align="center" valign="middle" rowspan="1" colspan="1">125.6</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Trans</td><td align="center" valign="middle" rowspan="1" colspan="1">111.5</td><td align="center" valign="middle" rowspan="1" colspan="1">117.6</td><td align="center" valign="middle" rowspan="1" colspan="1">135</td><td align="center" valign="middle" rowspan="1" colspan="1">113.68</td><td align="center" valign="middle" rowspan="1" colspan="1">114.1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Post</td><td align="center" valign="middle" rowspan="1" colspan="1">115.6</td><td align="center" valign="middle" rowspan="1" colspan="1">117.2</td><td align="center" valign="middle" rowspan="1" colspan="1">120</td><td align="center" valign="middle" rowspan="1" colspan="1">115.28</td><td align="center" valign="middle" rowspan="1" colspan="1">133</td></tr><tr><td rowspan="3" align="center" valign="middle" colspan="1">Intervention</td><td align="center" valign="middle" rowspan="1" colspan="1">Pre</td><td align="center" valign="middle" rowspan="1" colspan="1">113.7</td><td align="center" valign="middle" rowspan="1" colspan="1">116.9</td><td align="center" valign="middle" rowspan="1" colspan="1">122</td><td align="center" valign="middle" rowspan="1" colspan="1">119.2</td><td align="center" valign="middle" rowspan="1" colspan="1">127.5</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Trans</td><td align="center" valign="middle" rowspan="1" colspan="1">116.0</td><td align="center" valign="middle" rowspan="1" colspan="1">115.8</td><td align="center" valign="middle" rowspan="1" colspan="1">110</td><td align="center" valign="middle" rowspan="1" colspan="1">116.48</td><td align="center" valign="middle" rowspan="1" colspan="1">117.9</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Post</td><td align="center" valign="middle" rowspan="1" colspan="1">114.1</td><td align="center" valign="middle" rowspan="1" colspan="1">116</td><td align="center" valign="middle" rowspan="1" colspan="1">121</td><td align="center" valign="middle" rowspan="1" colspan="1">116.8</td><td align="center" valign="middle" rowspan="1" colspan="1">118</td></tr><tr><td rowspan="6" align="center" valign="middle" colspan="1">Oxigen saturation (%)</td><td rowspan="3" align="center" valign="middle" colspan="1">Control</td><td align="center" valign="middle" rowspan="1" colspan="1">Pre</td><td rowspan="6" align="center" valign="middle" colspan="1">NR</td><td align="center" valign="middle" rowspan="1" colspan="1">99.9</td><td rowspan="6" align="center" valign="middle" colspan="1">NR</td><td align="center" valign="middle" rowspan="1" colspan="1">97.8</td><td align="center" valign="middle" rowspan="1" colspan="1">98.2</td><td align="center" valign="middle" rowspan="1" colspan="1">97.42</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Trans</td><td align="center" valign="middle" rowspan="1" colspan="1">99.9</td><td align="center" valign="middle" rowspan="1" colspan="1">97.45</td><td align="center" valign="middle" rowspan="1" colspan="1">98.2</td><td align="center" valign="middle" rowspan="1" colspan="1">97.25</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Post</td><td align="center" valign="middle" rowspan="1" colspan="1">100</td><td align="center" valign="middle" rowspan="1" colspan="1">97.20</td><td align="center" valign="middle" rowspan="1" colspan="1">98.12</td><td align="center" valign="middle" rowspan="1" colspan="1">97.62</td></tr><tr><td rowspan="3" align="center" valign="middle" colspan="1">Intervention</td><td align="center" valign="middle" rowspan="1" colspan="1">Pre</td><td align="center" valign="middle" rowspan="1" colspan="1">99.9</td><td align="center" valign="middle" rowspan="1" colspan="1">97.15</td><td align="center" valign="middle" rowspan="1" colspan="1">97.96</td><td align="center" valign="middle" rowspan="1" colspan="1">97.5</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Trans</td><td align="center" valign="middle" rowspan="1" colspan="1">99.9</td><td align="center" valign="middle" rowspan="1" colspan="1">96.85</td><td align="center" valign="middle" rowspan="1" colspan="1">98.2</td><td align="center" valign="middle" rowspan="1" colspan="1">98.57</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Post</td><td align="center" valign="middle" rowspan="1" colspan="1">100</td><td align="center" valign="middle" rowspan="1" colspan="1">96.55</td><td align="center" valign="middle" rowspan="1" colspan="1">98.28</td><td align="center" valign="middle" rowspan="1" colspan="1">99.02</td></tr></tbody></table><table-wrap-foot><fn><p>bpm: beats per minute, mmHG: millimeters of mercury, %: percent, pre: preoperative, trans: transoperative (between 15 to 20 minutes), post: postoperative (from 60 minutes), NR: not reported.
</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="T4"><label>Table 4</label><caption><p>Pain, sedation and satisfaction.</p></caption><table frame="border" rules="all" width="100%"><thead><tr><th rowspan="2" colspan="1">Author/year of publication</th><th colspan="2" rowspan="1">Pain</th><th colspan="2" rowspan="1">Sedation</th><th colspan="2" rowspan="1">Patient satisfaction</th></tr><tr><th rowspan="1" colspan="1">Control</th><th rowspan="1" colspan="1">Intervention</th><th rowspan="1" colspan="1">Control</th><th rowspan="1" colspan="1">Intervention</th><th rowspan="1" colspan="1">Control</th><th rowspan="1" colspan="1">Intervention</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Yamane, 2015</td><td align="center" valign="middle" rowspan="1" colspan="1">927m (CPT)</td><td align="center" valign="middle" rowspan="1" colspan="1">1039m (CPT)</td><td align="center" valign="middle" rowspan="1" colspan="1">NR</td><td align="center" valign="middle" rowspan="1" colspan="1">NR</td><td align="center" valign="middle" rowspan="1" colspan="1">NR</td><td align="center" valign="middle" rowspan="1" colspan="1">NR</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ouchi, 2016</td><td align="center" valign="middle" rowspan="1" colspan="1">NR</td><td align="center" valign="middle" rowspan="1" colspan="1">NR</td><td align="center" valign="middle" rowspan="1" colspan="1">Mackenzie and grant sedation score (1-5)
10 minutes
Level 1: 17 Patients
Level 2: 1 Patient
60 minutes
Level 1: 17 Patients
Level 2: 1 Patient</td><td align="center" valign="middle" rowspan="1" colspan="1">Mackenzie and grant sedation score (1-5)
10 minutes
Dex 2.5%
Level 1: 18 Patients
Dex 5.0%
Level 1: 17 Patients
Level 2: 1 Patient
Dex 7.5%
Level 1: 18 Patients
60 minutes
Dex 2.5%
Level 1: 18 Patients
Dex 5.0%
Level 1: 14 Patients
Level 2: 3 Patients
Level 3: 1 Patient
Dex 7.5%
Level 1: 17 Patients
Level 2: 1 Patient</td><td align="center" valign="middle" rowspan="1" colspan="1">NR</td><td align="center" valign="middle" rowspan="1" colspan="1">NR</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ouchi, 2020</td><td align="center" valign="middle" rowspan="1" colspan="1">NR</td><td align="center" valign="middle" rowspan="1" colspan="1">NR</td><td align="center" valign="middle" rowspan="1" colspan="1">Mackenzie and grant sedation score (1-5)
10 minutes
Level 1: 19 Patients
60 minutes
Level 1: 18 Patients
Level 2: 1 Patient</td><td align="center" valign="middle" rowspan="1" colspan="1">Mackenzie and grant sedation score (1-5)
10 minutes
Dex 1.0 ppm
Level 1: 19 Patients
Dex 2.0 ppm
Level 1: 18 Patients
Level 2: 1 Patient
60 Minutes
Dex 1.0 ppm
Level 1: 18 Patients
Level 2: 1 Patient
Dex 2.0 ppm
Level 1: 16 Patients
Level 2: 1 Patient</td><td align="center" valign="middle" rowspan="1" colspan="1">NR</td><td align="center" valign="middle" rowspan="1" colspan="1">NR</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Alizargar, 2021</td><td align="center" valign="middle" rowspan="1" colspan="1">NR</td><td align="center" valign="middle" rowspan="1" colspan="1">NR</td><td align="center" valign="middle" rowspan="1" colspan="1">NR</td><td align="center" valign="middle" rowspan="1" colspan="1">NR</td><td align="center" valign="middle" rowspan="1" colspan="1">High: 16 Patients (80%)
Intermediate:
1 Patient (20%)</td><td align="center" valign="middle" rowspan="1" colspan="1">High: 19 Patients (95%)
Intermediate:
1 Patient (5%)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Patil, 2022</td><td align="center" valign="middle" rowspan="1" colspan="1">6h: 1.8 (VAS)
12h: 2.7 (VAS)
24h: 3.7 (VAS)
48h: 3.7 (VAS)
72h: 3.7 (VAS)</td><td align="center" valign="middle" rowspan="1" colspan="1">6h: 0 (VAS)
12h: 0.3 (VAS)
24h: 1.0 (VAS)
48h: 1.6 (VAS)
72h: 1.6 (VAS)</td><td align="center" valign="middle" rowspan="1" colspan="1">NR</td><td align="center" valign="middle" rowspan="1" colspan="1">NR</td><td align="center" valign="middle" rowspan="1" colspan="1">1. Bad: 3 (7.89%)
2. Moderate: 8 (21.05%)
3. Good: 14 (36.84%)
4. Excellent: 13 (34.21%)</td><td align="center" valign="middle" rowspan="1" colspan="1">1. Bad: 1 (2.63)
2. Moderate: 5 (13.15)
3. Good: 10 (26.31)
4. Excellent: 22 (57.89)</td></tr></tbody></table><table-wrap-foot><fn><p>NR: not reported, m: minutes, CPT: Current Perception Threshold, %: percent, h: hour, VAS: Visual Analogic Scale, ppm: parts per million, DEX: Dexmedetomidine.
</p></fn></table-wrap-foot></table-wrap></floats-group></article>